BAYRY - Bayer Aktiengesellschaft

Other OTC - Other OTC Delayed Price. Currency in USD
23.77
+0.19 (+0.78%)
As of 3:59PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close23.58
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume2,878
Avg. Volume654,420
Market Cap91.889B
Beta1.24
PE Ratio (TTM)9.88
EPS (TTM)2.41
Earnings DateN/A
Forward Dividend & Yield0.81 (2.93%)
Ex-Dividend Date2018-05-25
1y Target Est35.33
Trade prices are not sourced from all markets
  • Jury orders Monsanto to pay $289 million in Roundup cance...
    CNBC Videos2 days ago

    Jury orders Monsanto to pay $289 million in Roundup cance...

    CNBC's Aditi Roy reports on the verdict of the first of thousands of similar cases against Monsanto involving the company's Roundup weed-killer.

  • Jury orders Monsanto to pay $289 million in Roundup cance...
    CNBC Videos2 days ago

    Jury orders Monsanto to pay $289 million in Roundup cance...

    CNBC's Aditi Roy reports on the lawsuit against Monsanto over its allegedly carcinogenic herbicide, Roundup.

  • Bayer shares plunge on Monsanto cancer payout
    Reuters Videos2 days ago

    Bayer shares plunge on Monsanto cancer payout

    Shares in Bayer plunged more than 10 percent to their lowest in almost two years after a California jury ordered the German company's subsidiary Monsanto to pay $289 million in damages last week. As David Doyle reports, a jury found Monsanto liable in a lawsuit alleging that the company's glyphosate-based weedkillers, including its Roundup brand, caused cancer.

  • 3 Top Stocks in Digital Agriculture
    Motley Fool1 hour ago

    3 Top Stocks in Digital Agriculture

    Companies across the agricultural value chain are investing in digital tools to help farmers. Here are three to put on your radar.

  • Reuters3 hours ago

    Analysis: Monsanto Roundup appeal has uphill climb on 'junk science' grounds - legal experts

    Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • The Wall Street Journal13 hours ago

    [$$] David Einhorn’s Bayer Pick Hit in Monsanto Ruling

    A top stock pick of hedge-fund manager David Einhorn was stung this week by the loss of a crucial case in California, the latest potential setback for the billionaire investor. Shares in Bayer AG fell sharply on Monday after Monsanto Co.—which the German chemical company recently acquired—was ordered to pay $289.2 million in a landmark lawsuit over whether exposure to two of its weed killers caused cancer. The ruling by a California state jury on Friday found that Monsanto’s Roundup and Ranger Pro products presented a “substantial danger” to consumers, and that the St. Louis-based company knew—or should have known—the potential risks they posed.

  • Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
    Reuters16 hours ago

    Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts

    Bayer AG (BAYGn.DE) unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit
    Zacks23 hours ago

    Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit

    Shares of Bayer (BAYRY) crash as its newly acquired company Monsanto was fined $289 million over allegations that its weedkiller caused cancer.

  • Market Exclusiveyesterday

    Market Morning: EM Rout Halts, Erdogan Threatens Apple, Bayer Gets Rounded Up

    Futures Bounce, Emerging Market Collapse Subsides Stock futures are up in the United States as the US dollar has declined slightly versus a basket of emerging market currencies that have finally found their footing overnight, for now. Emerging Market stocks (NYSEARCA:EEM) have stabilized as well, though the question is for how long. Is this a […] The post Market Morning: EM Rout Halts, Erdogan Threatens Apple, Bayer Gets Rounded Up appeared first on Market Exclusive.

  • In Monsanto, Bayer Investors Inherit Hard-to-Predict Risk
    Bloombergyesterday

    In Monsanto, Bayer Investors Inherit Hard-to-Predict Risk

    Bayer AG investors can take heart that a $289 million verdict against its newly acquired Monsanto unit will be challenged on appeal, but they’re not wrong to dread thousands more lawsuits alleging that the company’s popular Roundup herbicide causes cancer. Some financial analysts predicted the Aug. 10 jury award in San Francisco will be knocked down or wiped out entirely, while legal experts warned of more uncertainty ahead. More than 5,000 U.S. residents have joined similar lawsuits against Monsanto -- and the lawyer who won the trial said an equal number are poised to file new claims.

  • The Wall Street Journalyesterday

    [$$] Bayer Shares Plunge After Monsanto Weed Killer Ruling

    Shares in Bayer AG fell sharply on Monday after Monsanto Co.—which the German chemical company recently acquired—was ordered to pay $289.2 million in a landmark lawsuit over whether exposure to two of its weed killers caused cancer. The ruling by a California state jury on Friday found that Monsanto’s Roundup and Ranger Pro products presented a “substantial danger” to consumers, and that the St. Louis-based company knew—or should have known—the potential risks they posed. The case is the first of many that could go to trial and represents a nagging issue for Bayer, which closed its $60 billion-plus acquisition of Monsanto in June after two years of wrangling.

  • The Wall Street Journal2 days ago

    [$$] Monsanto Gives Investors a New Reason to Avoid Bayer

    The optimistic case for German chemical giant Bayer’s unpopular effort to buy Monsanto was that after the deal closed investors would appreciate the value of a new global leader in seeds and herbicides. Instead, Bayer is saddled with billions of dollars in potential legal liabilities and the possibility that a core business is at risk. A jury in San Francisco ruled late Friday that Monsanto’s flagship weed killer, Roundup, posed a “substantial danger” to consumers, and awarded $289.2 million in damages to a school groundskeeper, Dewayne “Lee” Johnson, who suffers from cancer.

  • Court rules against Monsanto
    Bloomberg2 days ago

    Court rules against Monsanto

    Bayer took a $11 billion hit after a court ruled in favor of a man who claims Monsanto's herbicide Roundup caused his cancer #tictocnews https://bloom.bg/2OZXxo5 (Source: Bloomberg)

  • Why a Roundup Lawsuit Caused Bayer A.G.'s to Tumble 11.3% Today
    Motley Fool2 days ago

    Why a Roundup Lawsuit Caused Bayer A.G.'s to Tumble 11.3% Today

    A $289 million dollar verdict by a California jury could mean Bayer's on the hook for billions in damages tied to Roundup.

  • TheStreet.com2 days ago

    Dow Down Triple Digits; Stocks End Near Day's Lows

    Monday Roundup The Turkish lira pulled back from record lows against the dollar as the central bank offered more liquidity to combat outflows sparked by the U.S. doubling metal tariffs on the country.

  • Investor's Business Daily2 days ago

    Stocks Open Higher As Tesla, Nielsen, Amazon Take Early Gains

    Tesla, Intel and Amazon were early leaders Monday as stocks opened to narrow gains, despite global weakness linked to Turkey's currency crisis.

  • Bloomberg2 days ago

    Despite Monsanto Trial Verdict, World Still Needs Pesticides

    It may seem like Judgment Day has come for glyphosate, with a California jury slapping $289 million in damages on Monsanto Co. in a cancer trial, and a federal judge in Brazil halting the herbicide use over health concerns -- all in the space of a week. Dramatic headlines are par for the course for Monsanto, a company that activists have targeted for decades and which Germany’s Bayer AG just bought for $66 billion. Bayer shares tumbled Monday on concerns over a protracted legal battle, but Monsanto has weathered these kinds of storms before since its herbicide and the genetically modified crops it’s used on have become such a critical part of modern agriculture.

  • Benzinga2 days ago

    Bayer Shares Fall After Jury Awards $289M In Roundup Lawsuit

    Hundreds of consumers have claimed the most popular weed killer on the market causes cancer, according to a report by CNN. On Friday, a California jury found that Monsanto failed to warn consumers of potential cancer risks from its weed killers. The lawsuit began with a school groundskeeper, Dewayne Johnson , who was diagnosed with terminal cancer that he argued was caused by Roundup.

  • Reuters2 days ago

    European stocks dips to 3-week low as Turkey dents lenders

    By Helen Reid LONDON (Reuters) - Banks dragged European shares down on Monday as the Turkish currency crisis shook investor confidence in lenders exposed to the country, while pharmaceuticals group Bayer ...

  • Roundup cancer verdict sends Bayer shares sliding
    Reuters2 days ago

    Roundup cancer verdict sends Bayer shares sliding

    Bayer shares plunged as much as 14 percent on Monday, losing about $14 billion in value, after newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict in favour of a California school groundskeeper with terminal cancer, Monsanto faces more than 5,000 similar lawsuits across the United States over claims it did not warn of the cancer risks of glyphosate-based weedkillers, including its Roundup brand. Monsanto, bought by Bayer this year for $63 billion, said that it would appeal against the jury's verdict in California, which is the latest episode in a long-running debate over claims that exposure to Roundup can cause cancer.

  • Reuters2 days ago

    Germany aims to end use of glyphosate in this legislative period: spokesman

    Use of glyphoste-based weed-killers should be halted during the current legislative period which ends in three years, a spokesman for the German environment ministry said on Monday. Shares of Germany's ...

  • Roundup cancer verdict sends Bayer shares sliding
    Reuters2 days ago

    Roundup cancer verdict sends Bayer shares sliding

    Bayer (BAYGn.DE) shares plunged as much as 14 percent on Monday, losing about $14 billion in value, after newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict in favor of a California school groundskeeper with terminal cancer, Monsanto faces more than 5,000 similar lawsuits across the United States over claims it did not warn of the cancer risks of glyphosate-based weedkillers, including its Roundup brand. Monsanto, bought by Bayer this year for $63 billion, said that it would appeal against the jury's verdict in California, which is the latest episode in a long-running debate over claims that exposure to Roundup can cause cancer.

  • All of Monsanto's Problems Just Landed on Bayer
    Bloomberg2 days ago

    All of Monsanto's Problems Just Landed on Bayer

    The true price of Bayer AG's purchase of Monsanto Co. is suddenly in doubt after the U.S. crop science behemoth lost a court case over claims its Roundup weed killer causes cancer. On Friday, a San Francisco state court hit Monsanto with $289 million in damages. The company, owned by Bayer since June but operating separately pending the completion of antitrust conditions, says the product is safe.

  • Investopedia2 days ago

    Bayer Shares Plunge After Monsanto Loses First of Many Cancer Trials

    Shares in Bayer AG (BAYRY) plunged more than 10% in early morning trade on Monday after Monsanto lost a case and looked set for more legal trouble in the near future. The verdict against Monsanto, which Bayer acquired in June for $63 billion, has placed a dark cloud over its parent company’s shares. There are currently more than 5,000 similar lawsuits in the U.S. against Monsanto’s weed killers, according to Reuters, with Johnson’s trial coming first because doctors claimed that he was close to dying.

  • Financial Times2 days ago

    [$$] Bayer shares tumble after Roundup cancer ruling

    Shares in Bayer plunged more than 10 per cent on Monday, as investors feared that the German pharmaceuticals and chemicals group could face an avalanche of costly legal defeats linked to a weedkiller made ...